Gene Query: COPE

Dataset Description Geneva Score
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 39.03
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 36.22
Dtx3L and Androgen Signaling in Prostate Cancer 31.27
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 30.02
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 29.67
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 27.4
Differentiation enhances Zika virus infection in neuronal brain cells 27.18
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 27.01
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 25.16
Stem and effector CD8 T-cells from human cancers 23.89
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 23.55
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 22.48
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 22.26
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 22.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 22.17
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 22.09
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 22.09
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 21.87
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 21.43
Studying the selectivity of a small molecule Synucleozid on transcriptome 21.18
High-Throughput Kinetic Analysis of Fractional Killing 21.05
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 19.68
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 19.29
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 18.81
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 18.72
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 18.31
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 18.1
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 17.89
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 17.87
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 17.66
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 17.66
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 17.43
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 17.15
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 17.15
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 16.99
LncRNA expression profiling of ischemic stroke patients 16.89
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 16.65
Comprehensive comparative analysis of 5’ end RNA sequencing methods 16.54
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 16.48
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 16.44
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 15.32
hTERT promotes cell adhesion and migration independent of telomerase activity 15.09
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 14.67
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 14.67
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 14.65
Gene expression analysis of dengue-infected cells 14.09
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 13.74
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 13.61
Global analysis of enhancer targets: Mosaic-seq 13.41
RNA sequencing of primary human platelets and in vitro cell lines 13.37
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 13.26
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 13.12
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 13.09
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 12.8
Human Treg NaCl stimulation 12.74
U1 snRNP telescripting regulates size-function stratified human genome 12.65
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 12.6
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 12.48
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 12.4
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 12.36
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 12.23
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 12.22
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 12.22
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.14
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.12
NRDE2 negatively regulates nuclear exosome functions 12.1
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 12.06
HNF1 regulates critical functions of the human epididymis epithelium. 11.83
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 11.83
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 11.7
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 11.59
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 11.57
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.48
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 11.4
RNA-seq of cells with TET1 knockout 11.18
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 11.18
CROP-Seq in Primary Human T Cells 11.17
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 11.17
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.16
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 11.06
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 10.92
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.89
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 10.88
The comparison of high-throughput single-cell RNA-seq methods 10.84
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 10.74
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.73
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.73
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.7
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 10.64
Global transcriptome analysis of HAP1 cells 10.63
RNA m5C Methylation in breast cancer using MeRIP-Seq 10.61
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 10.59
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.59
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 10.56
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 10.55
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 10.55
METTL3 promotes translation in human cancer cells 10.43
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.33
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 10.28
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.08
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 10.07
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 10.07
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 10.05
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 9.89
The human blood-nerve barrier transcriptome 9.85
Genome-wide analysis of Dengue virus 2 infected cells 9.79
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 9.63
Region-specific Innate Antiviral Responses of the Human Epididymis 9.61
RNAseq Analysis in glioblastoma cells treated with Mepazine 9.59
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.54
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 9.51
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.4
Hepatitis C virus functionally sequesters miR-122 9.4
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.4
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 9.29
Expression and functions of long noncoding RNAs during human T helper cell differentiation 9.23
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 9.2
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.16
Global analyses of the effect of different cellular contexts on microRNA targeting 9.16
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 9.16
Landscape and variation of RNA secondary structure across the human transcriptome 9.06
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 8.97
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 8.96
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 8.9
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 8.75
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 8.74
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 8.71
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 8.71
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 8.71
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.6
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.54
Lipid degradation promotes prostate cancer cell survival 8.54
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.53
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 8.53
Retinoic acid suppresses MYB in adenoid cystic carcinoma 8.53
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 8.52
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.46
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.46
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.41
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.41
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.4
Mitochondrial dsRNA triggers antiviral signalling in humans 8.4
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.37
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 8.37
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 8.3
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 8.26
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 8.26
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 8.19
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 8.19
High-throughput sequencing of pluripotent cells 8.16
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 8.16
Tracking distinct RNA populations using efficient and reversible covalent chemistry 8.13
RNA-sequencing of human liver tissue 8.11
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 8.06
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 8.04
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.01
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 7.99
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.98
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.9
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.9
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.89
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.89
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.86
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 7.85
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.85
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 7.85
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 7.82
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.82
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.82
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.79
DAOY-Notch1/Notch2 knockout: transcriptome comparison 7.78
Transcriptional profiling of microglia; current state of the art and future perspectives 7.78
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.74
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.6
An optimization system for isolating and sequencing of single human colon cancer cells 7.58
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.58
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 7.55
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 7.53
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 7.53
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.53
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.53
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 7.43
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 7.36
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 7.36
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 7.33
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 7.33
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.31
Proteomics identifies a marker signature of MAPKi resistance in melanoma 7.29
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.28
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 7.27
PRDM1 inhibits proliferation of human colon cancer organoids 7.23
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.23
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.15
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 7.13
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 7.13
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 7.13
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.11
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 7.11
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 7.11
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.08
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 7.05
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 7.05
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 7.0
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.95
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 6.94
Regulation of hypoxia-inducible factor activity by ZMYND8 6.92
RNA-seq of naive and primed ES cells (NHSM) 6.91
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.84
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.84
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 6.77
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 6.77
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.77
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 6.76
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 6.75
RNA editing in nascent RNA affects pre-mRNA splicing 6.7
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 6.66
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 6.65
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.65
Ectoderm specification of H1 human embryonic stem cells 6.55
TT-Seq captures the human transient transcriptome 6.53
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.47
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.45
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 6.39
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.35
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 6.31
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.18
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 6.14
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 6.14
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.13
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.11
Gene expression profiling of leukemia cells following asparagine depletion 6.03
Activity-dependent transcriptional changes in human neurons 6.0
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.98
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 5.96
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.95
scRNASeq analysis of cycling cardiomyocytes 5.89
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 5.83
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.8
Illumina Total RNA-seq in HeLa 5.77
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.75
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.74
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.68
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 5.67
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 5.67
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.66
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.61
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.57
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.56
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.51
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.51
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.42
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.37
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 5.32
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 5.32
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.31
Regulation of poly(A) tail and translation during the somatic cell cycle 5.31
High-throughput sequencing of PROMPT-enriched samples. 5.29
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.26
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.26
Effect of FGF13 depletion on the H460 cell line 5.22
Unique features and clinical importance of acute alloreactive immune responses 5.22
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 5.21
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.17
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 5.13
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 5.13
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 5.11
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.1
Effect of PBK knockdown on C4-2 cell transcriptome 5.01
IMP3 regulated gene expression in breast cancer cells 4.97
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.96
METTL3 and WTAP 4.93
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 4.91
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.86
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.86
N6-methyladenine DNA Modification in Glioblastoma 4.84
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.84
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.84
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.8
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.79
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.76
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 4.75
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.66
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 4.64
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.62
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 4.61
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 4.6
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 4.6
Transciptomic profiling of human fetal lung samples 4.59
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.57
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.55
Transcription elongation regulates genome 3D structure 4.46
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.39
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.39
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.32
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.31
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 4.3
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.28
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.26
Transcriptome sequencing of K-562 cells 4.23
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.23
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.23
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 4.22
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 4.2
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 4.2
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 4.17
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.17
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.16
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.16
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.16
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.15
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.15
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.14
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.14
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 4.1
Endothelial gene expression analysis 4.06
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 4.06
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.05
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 4.03
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 4.03
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.02
Zika virus directly infects human peripheral neurons and induces cell death 4.02
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.99
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 3.99
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 3.99
Positively selected enhancer elements endow tumor cells with metastatic competence 3.89
Cajal bodies are linked to genome conformation [RNA-Seq] 3.87
Cajal bodies are linked to genome conformation 3.87
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.86
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 3.83
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.82
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 3.75
Differential responses of human fetal brain neural stem cells to Zika virus infection 3.73
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.69
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 3.64
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.62
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.61
Identification of global XBP1s target gene expression in human prostate cancer cells 3.54
Ebola virus (EBOV) infection of ARPE-19 cells 3.53
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.44
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.41
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 3.41
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.4
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 3.36
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.35
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.35
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.35
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.33
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.32
RNA-sequencing of healthy human skeletal myocytes 3.31
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 3.26
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.26
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.24
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.2
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.19
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 3.12
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.11
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 3.1
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.07
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.06
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.06
RNAseq of cell lines with knocked in ESR1 mutations 3.05
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 3.04
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.01
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.99
Downregulation of DDX5/DDX17 and REST 2.96
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.85
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.81
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.77
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.76
Comparative Analysis of Cas9 Activators Across Multiple Species 2.76
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.73
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.7
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.66
m6A-dependent regulation of messenger RNA stability 2.64
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.61
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.59
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 2.58
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 2.58
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.57
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 2.56
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.55
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.49
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.43
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.42
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 2.42
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.41
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.4
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.37
mRNA recovered upon RNF219 IP. [RNA-IP] 2.36
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 2.35
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.31
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.31
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.3
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.3
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.29
Toxoplasma gondii infection of human retinal pigment epithelial cells 2.26
miR-93 Targets in Human Endothelial Cells 2.22
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.12
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.11
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.1
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.0
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.0
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.98
Expression profiling of MCF-7 cells with treatment of TCDD 1.95
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.95
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 1.93
Interaction between mitoNEET and NAF-1 in cancer cells 1.87
Transcriptomes in healthy and CHB fetal hearts 1.78
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.77
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.75
Induced DNA demethylation, genome instability and transcription 1.75
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.75
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.72
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.71
RNA-seq differential expression studies: more sequence, or more replication? 1.71
miRNAs affected by antagomiR-17 treatment 1.64
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.62
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.58
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.58
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.56
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.52
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.52
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.5
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 1.48
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 1.44
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.42
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.41
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.41
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.37
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.31
Downregulation of LATS kinases alters p53 to promote cell migration 1.22
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.18
Iron response of HepG2 cells 1.13
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.12
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.1
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.04
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.04
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.04
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.02
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.02
Human Treg IFNg/IL-10 subpopulations 0.97
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.94
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.89
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.86
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.85
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.85
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.83
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.83
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.83
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.78
RNA-seq data from human lymphoma cell lines 0.77
ChIP-seq and RNA-seq from human lymphoma cell lines 0.77
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.74
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.74
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.71
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.71
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.7
The bromodomain protein BRD4 regulates splicing during heat shock 0.7
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.66
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.58
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.58
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.58
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.55
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.52
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.51
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.5
Enhancer activation during EGF response 0.48
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.47
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.39
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.36
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.33
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.31
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.31
SRSF1 role in cellular gene expression and splicing 0.3
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.29
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.27
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.27
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.2
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.18
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.18
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.16
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 0.16
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.16
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 0.16
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.13
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.13
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.12
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.12
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.12
Effects of transcription on genome - nuclear lamina interactions 0.08
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.08
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.06
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.05
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.05
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.03
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.01
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation